Glucose Health (GLUC) & The Competition Head to Head Survey

Glucose Health (OTCMKTS:GLUC) is one of 51 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its competitors? We will compare Glucose Health to similar companies based on the strength of its dividends, valuation, earnings, risk, analyst recommendations, institutional ownership and profitability.

Insider & Institutional Ownership

16.2% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 21.6% of shares of all “Medicinals & botanicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations for Glucose Health and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glucose Health	0	0	0	0	N/A
Glucose Health Competitors	272	537	980	74	2.46

As a group, “Medicinals & botanicals” companies have a potential upside of 62.84%. Given Glucose Health’s competitors higher probable upside, analysts plainly believe Glucose Health has less favorable growth aspects than its competitors.

Earnings and Valuation

This table compares Glucose Health and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Glucose Health	$540,000.00	-$420,000.00	-8.67
Glucose Health Competitors	$309.56 million	-$49.38 million	-8.58

Glucose Health’s competitors have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Glucose Health and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	-75.00%	N/A	N/A
Glucose Health Competitors	-42.21%	-22.72%	-7.72%

Volatility and Risk

Glucose Health has a beta of 3.49, suggesting that its share price is 249% more volatile than the S&P 500. Comparatively, Glucose Health’s competitors have a beta of 1.07, suggesting that their average share price is 7% more volatile than the S&P 500.

Summary

Glucose Health competitors beat Glucose Health on 6 of the 10 factors compared.

About Glucose Health

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.